![]()
|
|
||||||||
J. Biol. Chem., Vol. 256, Issue 4, 1695-1704, 02, 1981
E Cadman, R Heimer and C Benz
Pretreatment of L1210 cells with methotrexate in concentrations which
produced free intracellular methotrexate and near maximal inhibition of
dihydrofolate reductase resulted in an enhancement of intracellular 5-
fluorouracil (FUra) accumulation. This enhancement of FUra accumulation was
maximum (5-fold increase) after a 6-h exposure to 100 microM methotrexate.
The nucleotide derivatives of FUra, including a 5-fluoro-
2'-deoxyuridylate, and 5-fluorouridine-5'-triphosphate were also increased
nearly 5-fold following methotrexate treatment. In cells pretreated with
methotrexate, there was an increase in intracellular 5-
phosphoribosyl-1-pyrophosphate pools which ranged from 2 to 8 times control
values following concentrations of methotrexate between 0.1 microM and 10
microM. Both the increase in 5-phosphoribosyl-1- pyrophosphate and FUra
accumulation could be prevented by the addition of Leucovorin
(N5-formyltetrahydrofolate) at concentrations which rescued cells from the
inhibitory effects of methotrexate. Pretreatment with
6-methylmercaptopurine riboside, which inhibits
amidophosphoribosyltransferase, the first committed step in de novo purine
synthesis, also resulted in a similar elevation in 5-
phosphoribosyl-1-pyrophosphate pools and enhancement of FUra accumulation.
If the 5-phosphoribosyl-1-pyrophosphate pools were reduced following
methotrexate pretreatment by the addition to the cultures of hypoxanthine,
which utilizes 5-phosphoribosyl-1- pyrophosphate for the conversion to IMP,
the intracellular accumulation of FUra was not enhanced. Also, if the
inhibitor of 5-phosphoribosyl-1- pyrophosphate synthetase,
7-deazaadenosine, was given to cultures with methotrexate, there was no
increase in 5-phosphoribosyl-1-pyrophosphate pools, nor enhancement of FUra
accumulation. In addition, when 5-fluoro- 2'-deoxyuridine was added with
the methotrexate to cell cultures, there was no increase in
5-phosphoribosyl-1-pyrophosphate pools, nor enhancement of intracellular
FUra accumulation. These results indicate that the ability of methotrexate
to enhance FUra accumulation was probably the consequence of the antipurine
effect of methotrexate which resulted in a reduction of the complex
feedback inhibition on 5- phosphoribosyl-1-pyrophosphate synthesis and
utilization. The resultant increased 5-phosphoribosyl-1-pyrophosphate pools
were then capable of being utilized for the conversion of FUra to
5-fluorouridylate, the possible rate-limiting step in FUra intracellular
metabolism and the major determinant of the rate of intracellular FUra
accumulation. When methotrexate preceded FUra, there was synergistic cell
killing as determined by soft agar cloning. The exact mechanism of this
sequential synergistic antitumor activity may be the result of the enhanced
incorporation of FUra into RNA, since the increased 5-fluoro-2'-
deoxyuridylate which is formed is unlikely to increase substantially the
inhibition of dTMP synthesis induced by methotrexate pretreatment.
The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Aschele, D. Debernardis, R. Bandelloni, S. Cascinu, V. Catalano, P. Giordani, S. Barni, D. Turci, G. Drudi, S. Lonardi, et al. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil Ann. Onc., December 1, 2002; 13(12): 1882 - 1892. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |